ABSTRACT
Introduction
Fluid overload is a common problem in critically ill patients of intensive care units (ICU); a positive fluid balance is often associated with a poor outcome.
(1-4) Furosemide, a loop diuretic drug, is frequently administered to increase urinary output. Intravenous bolus injection is the traditional mode of administration to obtain prompt, vigorous diuresis. However, many concerns have been raised about possible marked intravascular volume fluctuations, toxicity and enhanced tolerance. (5, 6) Theoretically, continuous infusion of furosemide should allow better hemodynamic stability and less side effects, together with an easier achievement of the desired diuretic effect. Studies comparing continuous infusion and bolus injection have been undertaken in healthy volunteers, patients with chronic renal failure, children after cardiac surgery and patients with congestive heart failure (CHF). (7) (8) (9) (10) A recent review of the 2 modes of administration in CHF patients concluded that "the existing data still does not allow definite recommendations for clinical practice". (11) Furosemide related adverse effects can be enhanced in critically ill patients: their labile circulatory system can be markedly affected by intravascular volume depletion; besides that, electrolyte imbalance must be avoided. As a matter of fact, diuretic administration in critically ill patients with acute renal failure (ARF) has been associated with an increased risk of death and nonrecovery of renal function. (12) The aim of the present study was to compare effects and complications of continuous infusion of furosemide with those of bolus injections among critically ill patients in the ICU.
Materials and methods
Search Strategy P e r t i n e n t s t u dies were independently searched in PubMed (updated January 2009) by two trained investigators. The full PubMed search strategy, including the keywords furosemide, bolus, infusion and perfusion, was developed according to Biondi-Zoccai et al. (13) and is available in the appendix. In addition, we used backward snowballing (i.e. scanning of reference of retrieved articles and pertinent reviews) and we contacted international experts for further studies. No language restriction was enforced, and non-English-language articles were translated before further analysis. Study Selection References obtained from database and literature searches were first independently examined at the title/abstract level by two investigators, with divergences resolved by consensus, and then, if potentially pertinent, retrieved as complete articles. The following inclusion criteria were employed for potentially relevant studies: a) random allocation to treatment, b) comparison of furosemide bolus vs continuous infusion, c) performed in surgical or intensive care patients. The exclusion criteria were: a) non-parallel design (i.e. crossover) randomized trials, b) duplicate publications, c) non-human experimental studies d) no outcome data. Two investigators selected studies for the final analysis by independently assessing compliance with selection criteria. Divergences from the selection criteria were resolved by consensus. Data Abstraction and Study Characteristics Baseline, procedural and outcome data were independently abstracted by two investigators, with divergences resolved by consensus. The primary end-point of our analysis was to determine whether a continuous infusion of furosemide reduced hospital mortality as compared to bolus administration. Data Analysis and Synthesis Binary outcomes from individual studies were analyzed according to the Mantel-Haenszel model in order to compute individual odds ratios (OR) with pertinent 95% confidence intervals (CI), and a pooled summary effect estimate was calculated by means of fixed effects model. (14) Statistical heterogeneity and inconsistency was measured using, respectively, Cochrane Q tests and I2. Statistical significance was set at the two-tailed 0.05 level for hypothesis testing and at the 0.10 for heterogeneity testing. I2 values around 25%, 50% and 75% were considered representing respectively low, moderate and severe statistical inconsistency. Unadjusted P values are reported throughout. Computations were performed with SPSS 11.0 (SPSS, Chicago IL, USA) and RevMan 4.2 (a freeware available from The Cochrane Collaboration). The study was performed in compliance with The Cochrane Collaboration and the Quality of Reporting of Meta-Analysis (QUOUM) guidelines.
Results
Database searches, snowballing and contacts with experts yielded a total of 157 citations (figure 1). Excluding 148 non-pertinent titles or abstracts, we retrieved nine studies in complete form and assessed them according to the selection criteria. A total of five studies were further excluded because of their non-experimental design, including the use of historical controls, or because of duplicate publications. We finally identified four eligible randomized clinical trials, (14) (15) (16) (17) 2 ). The studies appeared of suboptimal quality, as testified by the common lack of details on the method used for randomization sequence generation and allocation. No RCT employed a multicenter design, a feature that does not strictly impact on internal validity but usually increases external validity of a trial.
Discussion
Currently available data from four small and relatively heterogeneous studies were insufficient to assess the merits of the two modes of furosemide administration in critically ill adult patients. Hospital mortality does not appear to differ. Diuretic treatment is widely used in ICU to resolve fluid overload or to treat (or prevent) ARF; furosemide is by far the most commonly prescribed drug, at least for ARF patients. (18) In patients with acute lung injury, furosemide shortens mechanical ventilation and ICU stay, without ameliorating mortality. (19) In contrast, administration of loop diuretics in adult patients is not associated with clinical benefits in the treatment or prevention of ARF, as two Despite the wide use of furosemide and the fact that continuous infusion intuitively seems superior than bolus injection, we lack evidence on this topic. Randomized controlled trials have focused on patients with congestive heart failure. A Cochrane review on the mode of administration of loop diuretics in this sub-group of patients found eight studies involving 254 patients. Studies were heterogeneous in terms of study population, dose, duration of the infusion, presence or absence of a loading dose. Continuous infusion appeared to (25) reported that a subgroup of nonrandomized (excluded for lacking of informed consent or unavailability of the research staff) patients in his study had less cumulative furosemide dose, less net diuresis, and longer ICU and hospital stay than randomized patients.
Conclusions
Furosemide in continuous perfusion was not associated with a significant existing data are insufficient to confidently assess the best way to administer furosemide . 
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